<sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
The aim of this narrative review is to evaluate the current status of <sup>177</sup>Lu-PSMA (prostate specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (mCRPC) in the light of the current literature. We also addressed patient preparation, therapy administration a...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2021-04-01
|
| Schriftenreihe: | Biomedicines |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2227-9059/9/4/430 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|